116P Real-world outcomes of patients with metastatic non-small cell lung cancer receiving 2L+ atezolizumab-based treatments in Taiwan clinical practice

Authors :: J. Shih
C-C. Wang
C-H. Kuo
S-G. Wu
J.-Y. Hung
T. Hsia
C. Chiang
C-Y. Su
C-F. Chen
Source :: Journal of Thoracic Oncology. 16:S761
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Real world outcomes
medicine.disease
Clinical Practice
Atezolizumab
Internal medicine
medicine
Non small cell
business
Lung cancer

Tools